Passage Bio, Inc.PASGNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P14
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-20.46%
2024-39.90%
2023-15.73%
2022-17.84%
202199.43%
2020333.23%
2019649.03%
20180.00%